822
Participants
Start Date
December 31, 2003
Study Completion Date
June 30, 2005
Roflumilast
ALTANA Pharma, Cities in Alabama
ALTANA Pharma, Cities in Arizona
ALTANA Pharma, Cities in Arkansas
ALTANA Pharma, Cities in California
ALTANA Pharma, Cities in Colorado
ALTANA Pharma, Cities in Connecticut
ALTANA Pharma, Cities in Delaware
ALTANA Pharma, Cities in Florida
ALTANA Pharma, Cities in Georgia
ALTANA Pharma, Cities in Illinois
ALTANA Pharma, Cities in Indiana
ALTANA Pharma, Cities in Kansas
ALTANA Pharma, Cities in Kentucky
ALTANA Pharma, Cities in Louisiana
ALTANA Pharma, Cities in Maine
ALTANA Pharma, Cities in Maryland
ALTANA Pharma, Cities in Massachusetts
ALTANA Pharma, Cities in Michigan
ALTANA Pharma, Cities in Minnesota
ALTANA Pharma, Cities in Missouri
ALTANA Pharma, Cities in Montana
ALTANA Pharma, Cities in Nebraska
ALTANA Pharma, Cities in Nevada
ALTANA Pharma, Cities in New Jersey
ALTANA Pharma, Cities in New York
ALTANA Pharma, Cities in North Carolina
ALTANA Pharma, Cities in Ohio
ALTANA Pharma, Cities in Oklahoma
ALTANA Pharma, Cities in Oregon
ALTANA Pharma, Cities in Pennsylvania
ALTANA Pharma, Cities in Rhode Island
ALTANA Pharma, Cities in South Carolina
ALTANA Pharma, Cities in Tennessee
ALTANA Pharma, Cities in Texas
ALTANA Pharma, Cities in Utah
ALTANA Pharma, Cities in Vermont
ALTANA Pharma, Cities in Virginia
ALTANA Pharma, Cities in Washington
ALTANA Pharma, Cities in West Virginia
ALTANA Pharma, Cities in Russia
ALTANA Pharma, Cities in the Ukraine
Lead Sponsor
AstraZeneca
INDUSTRY